Cancer clinical trials in the region Auvergne-Rhône-Alpes
445 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Ovarian / Fallopian tubes / Peritoneum cancer
#NCT05183984
#2023-504166-37-00
Epithelial ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer (PPC)
Serous high grade carcinoma (HGSOC)
Endometrioid carcinoma
Stage III
Locally Advanced
None
Surgery
Targeted therapy
Targeted therapy
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Groupe ARCAGY/GINÉCO
Phase 2
Colon cancer
Rectal cancer
#NCT06948448
#2024-519590-19-00
Adenocarcinoma
Locally Advanced
Metastatic
MSS/pMMR
None
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
Ono Pharmaceutical Co. Ltd.
Phase 2
Lymphoma
#NCT05283720
#2023-505347-38-00
B cell lymphoma
Follicular lymphoma
1
2
3 or more
Systemic Treatment-Naive
Bispecific T-cell engager antibodies
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Abbvie
Phase 2
Lymphoma
#NCT05283720
#2023-505347-38-00
B cell lymphoma
Mantel cell lymphoma
None
1
2
3 or more
Bispecific T-cell engager antibodies
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand)
Abbvie
Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT03547973
#2023-508302-24-00
Invasive bladder cancer
Urothelial carcinoma
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Centre Jean Perrin (Clermont Ferrand )
Gilead Sciences
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
1
2
3 or more
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Centre Léon Bérard (Lyon)
Apollomics
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
1
2
3 or more
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Centre Léon Bérard (Lyon)
Apollomics
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
None
Systemic Treatment-Naive
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Targeted therapy
Centre Léon Bérard (Lyon)
Apollomics
Phase 2
Lymphoma
#NCT06534437
#2024-513098-31-00
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
None
2
3 or more
Chemotherapy
Bispecific T-cell engager antibodies
Monoclonal antibodies
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Ryvu Therapeutics SA
Phase 2
Lung cancer
#NCT06552234
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
None
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Hôpital Louis Pradel (Bron ), Hôpitaux Nord-Ouest - Villefranche-sur-Saône (Gleizé), Centre Hospitalier Métropole Savoie (Chambéry)
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer